The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s methenamine hippurate tablets market report forecasts the methenamine hippurate tablets market size to grow to $11.52 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Methenamine Hippurate Tablets Market Report 2023 – https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

Methenamine Hippurate Tablets Market Size Forecast
The global methenamine hippurate tablets market is expected to grow from $8.34 billion in 2022 to $8.93 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global methenamine hippurate tablets market size is expected to grow to $11.52 billion in 2027 at a CAGR of 6.6%.

North America held the largest methenamine hippurate tablets market share.

Key Methenamine Hippurate Tablets Market Driver ­– Increase In Geriatric Population
According to the World Health Organisation, a United Nations specialised organisation based in Geneva that is responsible for international public health, one in every six people on the earth will be 60 or older by 2030. There will be 1.4 billion people over the age of 60 in 2021, up from 1 billion in 2020. By 2050, the worldwide population of people aged 60 and up will have doubled (to 2.1 billion). The number of persons aged 80 and more is expected to triple between 2020 and 2050, reaching 426 million. As a result, the growing geriatric population is propelling the methenamine hippurate tablets market forward.

Request for A Sample Of The Global Methenamine Hippurate Tablets Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

Key Methenamine Hippurate Tablets Market Trend – Product Innovation
To increase their market position, major businesses in the methenamine hippurate tablets market are creating unique products. Custex, a urinary health company based in the United States, for example, will launch Cystex Ultra Protection in August 2021. Cystex Ultra Protection contains probiotics, cranberries, vitamin A, and bio-shield technology. More than 90% of women should be able to use Cystex Ultra Protection to treat recurrent UTIs and maintain urinary tract health.

Methenamine Hippurate Tablets Market Segment
1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs
4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Methenamine Hippurate Tablets Market Major Players and Strategies
Major players in the methenamine hippurate tablets market are Validus Pharmaceuticals LLC, Alvogen, Micro Labs USA Inc., Aurobindo Pharma, Edenbridge Pharmaceuticals LLC, Kreative Organics, CorePharma LLC, Amneal Pharmaceuticals Inc., Viatris Inc., County Line Pharmaceuticals, Mylan N.V., McKesson Corporation, Nuray Chemicals Private Limited, Chemische Fabrik Berg, and Siegfried AG.

The Methenamine Hippurate Tablets Global Market Report 2023 covers regional data on methenamine hippurate tablets market size, methenamine hippurate tablets market trends and drivers, opportunities, strategies, and methenamine hippurate tablets market competitor analysis. The countries covered in the methenamine hippurate tablets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Methenamine hippurate tablets are used to treat persistent urinary tract infections caused by certain bacteria. It is not used to treat any other current infections.

View More Reports Related To The Methenamine Hippurate Tablets Market –
Tablets Global Market Report 2023
Multivitamin Capsules And Tablets Global Market Report 2023
Cough And Cold Preparations Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: